Your browser doesn't support javascript.
loading
Targeting VEGF and EGFR: a combination worth re-exploring?
Tchekmedyian, Vatche; Sherman, Eric J.
Affiliation
  • Tchekmedyian V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Sherman EJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: shermane@mskcc.org.
Lancet Oncol ; 19(8): 1007-1009, 2018 08.
Article in En | MEDLINE | ID: mdl-30001988
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ErbB Receptors / Squamous Cell Carcinoma of Head and Neck Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ErbB Receptors / Squamous Cell Carcinoma of Head and Neck Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States